Lumbar interlaminar epidural steroid injections for chronic low back- and lower extremity-pain in Sjogren's syndrome: A case report.
Case report
Chronic pain
Lumbar interlaminar epidural steroid injections
Sjogren's syndrome
Journal
International journal of surgery case reports
ISSN: 2210-2612
Titre abrégé: Int J Surg Case Rep
Pays: Netherlands
ID NLM: 101529872
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
08
01
2022
revised:
05
04
2022
accepted:
05
04
2022
pubmed:
20
4
2022
medline:
20
4
2022
entrez:
19
4
2022
Statut:
ppublish
Résumé
Peripheral nervous system involvement is very common in Sjogren's syndrome (SS); however, polyradiculopathy has been reported rarely in association with SS, and predominantly chronic forms have been described. Here, we reported a case from our Neurosurgery Department in Intan Medika KIM Hospital, Bangka Island, Pangkalpinang, Indonesia; as Academic Health System of Universitas Padjadjaran. A 32-year-old woman, diagnosed with Sjogren's syndrome that was characterized by anti-nuclear, anti-Ro, anti-La and anti dsDNA-antibodies positives since 3 years ago; consulted to our department for a chronic low back with a radicular pain in both lower limbs from the gluteal area to both feet together with numbness, hyperstesis and allodynia. The pain was evaluated by the visual analogue scale (VAS) score of 8; we then performed cervico-lumbal computed tomography (CT) scan that demonstrated multiple protruded discs of the cervical- and lumbar-spine. Pain was treated with lumbar interlaminar epidural steroid injections as a safe technique that allows relieving patient symptoms; after 10 min, the patient experienced an improvement in her pain with reduced scores to 0-1 in VAS, as well as a significant improvement on her quality of life later on. The use of lumbar interlaminar epidural steroid injections for an alternative therapeutic for neuropathic pain in SS gives a satisfactory result in terms of improvement of pain as well as a significant improvement on patients' quality of life.
Identifiants
pubmed: 35439726
pii: S2210-2612(22)00299-1
doi: 10.1016/j.ijscr.2022.107053
pmc: PMC9026938
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
107053Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Références
Medicine (Baltimore). 2004 Sep;83(5):280-291
pubmed: 15342972
Osteoporos Int. 2011 Feb;22(2):421-33
pubmed: 20552328
West J Med. 2000 Nov;173(5):306
pubmed: 11069861
Rheumatol Int. 2020 Aug;40(8):1259-1265
pubmed: 32533289
Curr Rev Musculoskelet Med. 2008 Dec;1(3-4):212-22
pubmed: 19468908
Clin Immunol. 2017 Sep;182:48-54
pubmed: 28428095
Autoimmun Rev. 2017 Jun;16(6):587-593
pubmed: 28411165
Best Pract Res Clin Rheumatol. 2012 Feb;26(1):105-17
pubmed: 22424197
Osteoporos Int. 2005 Dec;16(12):1999-2004
pubmed: 16172800
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
Dis Markers. 2010;29(3-4):123-30
pubmed: 21178271
Osteoporos Int. 2013 Jun;24(6):1827-33
pubmed: 23052940
Int J Surg. 2020 Dec;84:226-230
pubmed: 33181358
Muscle Nerve. 1992 May;15(5):531-42
pubmed: 1316553